Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 StudyFrançoise Huguet, Hervé Dombret, Thibaut Leguay et al.|Journal of Clinical Oncology|2009Cited by 562
Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 TrialXavier Thomas, D Fière, Tibor Kovacsovics et al.|Journal of Clinical Oncology|2004Cited by 547
Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALLPhilippe Rousselot, Oliver G. Ottmann, marie Magdelaine Coude et al.|Blood|2016Cited by 329
Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trialEmmanuelle Tavernier, Xavier Thomas, JM Boiron et al.|Leukemia|2007Cited by 258
Toward a <i>NOTCH1/FBXW7/RAS/PTEN</i> –Based Oncogenetic Risk Classification of Adult T-Cell Acute Lymphoblastic Leukemia: A Group for Research in Adult Acute Lymphoblastic Leukemia StudyAmélie Trinquand, Vahid Asnafi, Aline Schmidt et al.|Journal of Clinical Oncology|2013Cited by 252